To access this element change to forms mode OFF
Grant Award View - GA30189
Evaluation of a new therapeutic strategy for treatment of systemic...
GA ID:
GA30189
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
25-Oct-2018
Publish Date:
21-Dec-2018
Category:
Medical Research
Grant Term:
1-Jan-2019 to 31-Dec-2021
Value (AUD):
$576,806.56
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 17/18 1.1 Health and Medical Research
Grant Program:
Project
Grant Activity:
Evaluation of a new therapeutic strategy for treatment of systemic sclerosis and systemic lupus erythematosus
Purpose:
Scleroderma and lupus are painful and disabling autoimmune diseases that severely impact patient quality of life and, in severe cases, reduce lifespan. There are currently no cures or good treatments for either disease. This project aims to develop a new and specific treatment for scleroderma and lupus by targeting a protein of the immune system that controls inflammation in both diseases.
GO ID:
GO Title:
NHMRC Project Grant Scheme
Internal Reference ID:
GNT1162767
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Queensland University of Technology
Recipient ABN:
83 791 724 622
Grant Recipient Location
Suburb:
Brisbane City
Town/City:
Brisbane City
Postcode:
4000
State/Territory:
QLD
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW, QLD
Postcode:
Multiple
Country:
AUSTRALIA